Our study revealed a novel mechanistic pathway in DCM involving the upregulation of Decr1 and its downstream effects on PDK4‐mediated metabolic dysregulation in cardiomyocytes. This evidence concerns the gene DECR1 and familial dilated cardiomyopathy.